| Dendrimer as nanocarrier for drug delivery P Kesharwani, K Jain, NK Jain Progress in Polymer Science 39 (2), 268-307, 2014 | 1236 | 2014 |
| Controlled and novel drug delivery NK Jain CBS publishers & distributors, 1997 | 999 | 1997 |
| Dendrimer toxicity: Let's meet the challenge K Jain, P Kesharwani, U Gupta, NK Jain International journal of pharmaceutics 394 (1-2), 122-142, 2010 | 821 | 2010 |
| HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients X Castellsagué, L Alemany, M Quer, G Halec, B Quirós, S Tous, ... Journal of the National Cancer Institute 108 (6), djv403, 2016 | 793 | 2016 |
| Advances in green synthesis of nanoparticles A Gour, NK Jain Artificial cells, nanomedicine, and biotechnology 47 (1), 844-851, 2019 | 776 | 2019 |
| A PEGylated dendritic nanoparticulate carrier of fluorouracil D Bhadra, S Bhadra, S Jain, NK Jain International journal of pharmaceutics 257 (1-2), 111-124, 2003 | 737 | 2003 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 609* | 2021 |
| Dendrimers in oncology: an expanding horizon RK Tekade, PV Kumar, NK Jain Chemical reviews 109 (1), 49-87, 2009 | 584 | 2009 |
| Transfersomes—a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation S Jain, P Jain, RB Umamaheshwari, NK Jain Drug development and industrial pharmacy 29 (9), 1013-1026, 2003 | 510 | 2003 |
| Advances in controlled and novel drug delivery NK Jain CBS publishers & distributors, 2008 | 499 | 2008 |
| Dendrimers: novel polymeric nanoarchitectures for solubility enhancement U Gupta, HB Agashe, A Asthana, NK Jain Biomacromolecules 7 (3), 649-658, 2006 | 479 | 2006 |
| Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin AS Chauhan, S Sridevi, KB Chalasani, AK Jain, SK Jain, NK Jain, ... Journal of controlled release 90 (3), 335-343, 2003 | 477 | 2003 |
| Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization SK Jain, AM Awasthi, NK Jain, GP Agrawal Journal of controlled release 107 (2), 300-309, 2005 | 468 | 2005 |
| Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes V Dubey, D Mishra, T Dutta, M Nahar, DK Saraf, NK Jain Journal of controlled release 123 (2), 148-154, 2007 | 460 | 2007 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 457* | 2021 |
| Proniosome based transdermal delivery of levonorgestrel for effective contraception B Vora, AJ Khopade, NK Jain Journal of controlled release 54 (2), 149-165, 1998 | 434 | 1998 |
| A review of nanocarriers for the delivery of small interfering RNA P Kesharwani, V Gajbhiye, NK Jain Biomaterials 33 (29), 7138-7150, 2012 | 421 | 2012 |
| Pegnology: a review of PEG-ylated systems. D Bhadra, S Bhadra, P Jain, NK Jain Die Pharmazie 57 (1), 5-29, 2002 | 415 | 2002 |
| Folate and folate− PEG− PAMAM Dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice P Singh, U Gupta, A Asthana, NK Jain Bioconjugate chemistry 19 (11), 2239-2252, 2008 | 399 | 2008 |
| Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting D Bhadra, AK Yadav, S Bhadra, NK Jain International journal of pharmaceutics 295 (1-2), 221-233, 2005 | 358 | 2005 |
Dr. Rakesh K. Tekade (Associate Prof...NIPER-A, IIT-Jammu, UTSouthwestern Texas (USA); University of Hawaii (USA), UCLan (UK), IMU-MalaysiaVerified email at niperahm.ac.in